A role for eosinophils in transplant rejection

Krieger, 1996, CD4+ but not CD8+ cells are essential for allorejection, J. Exp. Med., 184, 2013, 10.1084/jem.184.5.2013

Chan, 1995, In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection, Transplantation, 59, 1155, 10.1097/00007890-199504270-00014

Piccotti, 1996, IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity, J. Immunol., 157, 1951, 10.4049/jimmunol.157.5.1951

VanBuskirk, 1996, Transfusion of polarized Th2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection, Transplantation, 62, 229, 10.1097/00007890-199607270-00014

Zelenika, 1998, Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells, J. Immunol., 161, 1868, 10.4049/jimmunol.161.4.1868

Matesic, 1998, Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells, J. Immunol., 161, 5236, 10.4049/jimmunol.161.10.5236

Honjo, 2000, Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab/H-2Kd54-68) that mediate transplant rejection, Transplantation, 70, 1516, 10.1097/00007890-200011270-00020

Sanderson, 1992, Interleukin-5, eosinophils, and disease, Blood, 79, 3101, 10.1182/blood.V79.12.3101.bloodjournal79123101

Kay, 1997, Eosinophils and eosinophil-associated cytokines in allergic inflammation, Int. Arch. Allergy Immunol., 113, 196, 10.1159/000237545

Foster, 1996, Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model, J. Exp. Med., 183, 195, 10.1084/jem.183.1.195

Coffman, 1989, Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice, Science, 245, 308, 10.1126/science.2787531

Simeonovic, 1997, Eosinophils are not required for the rejection of neovascularized fetal pig proislet xenografts in mice, J. Immunol., 158, 2490, 10.4049/jimmunol.158.5.2490

Braun, 2000, In the absence of CD8+ T cells, interleukin-5 and eosinophils promote the rejection of MHC class I- and II-disparate vascularized cardiac allograft, Eur. J. Immunol., 30, 1290, 10.1002/(SICI)1521-4141(200005)30:5<1290::AID-IMMU1290>3.3.CO;2-8

Le Moine, 1999, IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice, J. Immunol., 163, 3778, 10.4049/jimmunol.163.7.3778

Gleich, 1993, The biology of the eosinophilic leukocyte, Annu. Rev. Med., 44, 85, 10.1146/annurev.me.44.020193.000505

Grunig, 1998, Requirement for IL-13 independently of IL-4 in experimental asthma, Science, 282, 2261, 10.1126/science.282.5397.2261

Schleimer, 1992, Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1, J. Immunol., 148, 1086, 10.4049/jimmunol.148.4.1086

Rothenberg, 1995, Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin-4-induced tumor suppression, Proc. Natl. Acad. Sci. U. S. A., 92, 8960, 10.1073/pnas.92.19.8960

Collins, 1995, Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, J. Exp. Med., 182, 1169, 10.1084/jem.182.4.1169

Dong, 1999, IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice, Eur. J. Immunol., 29, 2130, 10.1002/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S

Gounni, 2000, Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils, Blood, 96, 2163, 10.1182/blood.V96.6.2163

Suzuki, 2000, Role of common cytokine receptor gamma chain- and Jak3-dependent signaling in the proliferation and survival of murine mast cells, Blood, 96, 2172, 10.1182/blood.V96.6.2172

Marone, 2000, Immunological interactions between human eosinophils and cardiac mast cells, 76, 118

Dubucquoi, 1994, Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion, J. Exp. Med., 179, 703, 10.1084/jem.179.2.703

Wedemeyer, 2000, Roles of mast cells and basophils in innate and acquired immunity, Curr. Opin. Immunol., 12, 624, 10.1016/S0952-7915(00)00154-0

Foucras, 2000, Dendritic cells prime in vivo alloreactive CD4+ T lymphocytes toward type 2 cytokine- and TGF-β-producing cells in the absence of CD8+ T cell activation, J. Immunol., 165, 4994, 10.4049/jimmunol.165.9.4994

Noble, 1998, Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses, J. Immunol., 160, 566, 10.4049/jimmunol.160.2.566

Shustov, 2000, Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity, J. Clin. Invest., 106, R39, 10.1172/JCI8876

Paul, 1999, Chronic allograft nephropathy: an update, Kidney Int., 56, 783, 10.1046/j.1523-1755.1999.00611.x

Le Moine, 1999, Critical roles for IL-4, IL-5 and eosinophils in chronic skin allograft rejection, J. Clin. Invest., 103, 1659, 10.1172/JCI5504

Baetta, 2000, Upregulation and activation of Stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model, Arterioscler. Thromb. Vasc. Biol., 20, 931, 10.1161/01.ATV.20.4.931

Ensminger, 2000, Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells, Transplantation, 70, 955, 10.1097/00007890-200009270-00013

Nolan, 1995, Role of the eosinophil in chronic vascular rejection of renal allografts, Am. J. Kidney Dis., 26, 634, 10.1016/0272-6386(95)90601-0

Martinez, 1993, Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils, Transplantation, 55, 909, 10.1097/00007890-199304000-00041

Youssem, 1992, Graft eosinophilia in lung transplantation, Hum. Pathol., 23, 1172, 10.1016/0046-8177(92)90036-3

Trull, 2000, Randomized trial of blood eosinophil count monitoring as a guide to corticosteroid dosage adjustment after heart transplantation, Transplantation, 70, 802, 10.1097/00007890-200009150-00017